CorMedix

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$104,275
$39,736
$39,081
$31,209
Gross Profit
93,080
37,874
37,484
30,034
EBITDA
57,314
20,519
20,815
13,608
EBIT
53,524
20,356
20,653
13,474
Net Income
108,562
19,827
20,643
13,464
Net Change In Cash
104,275
39,736
39,081
31,209
Free Cash Flow
30,350
29,967
19,726
-5,624
Cash
48,493
159,308
66,285
40,650
Basic Shares
86,214
71,918
68,975
61,508

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$43,472
$0
$65
$190
Gross Profit
40,281
-205
61
41
EBITDA
-18,978
-46,234
-30,051
-29,375
EBIT
-19,288
-46,304
-30,260
-29,552
Net Income
-17,930
-46,339
-29,701
-28,210
Net Change In Cash
43,472
0
65
190
Cost of Revenue
11,454
Free Cash Flow
-50,730
-38,736
-24,576
-22,580
Cash
40,650
43,642
43,374
53,317
Basic Shares
58,871
50,902
40,274
37,666

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$1.40
2025-06-30
$0.28
2025-03-31
$0.29